prolactin receptor. By subtracting the Mr of prolactin, it was calculated that the hormone was bound to species of Mr 43 000 and 28 000. These Mr values were not affected by reduction of solubilized membranes, suggesting that the structure of the prolactin receptor is not stabilized by interchain disulphide bonds between subunits. Subtracting the Mr of somatotropin from somatogenic complexes indicated that the hormone had bound to species of Mr 280000, 200000 and 100000. The 300000-and 220000-Mr complexes were not isolated from reduced membranes, whereas the amount of the 130 000-Mr species was augmented. These observations could suggest that a major component of the somatotropin receptor is a trimeric aggregate in which some subunits are retained in a larger complex by interchain disulphide bonds.
1251-labelled peptide hormones can be covaldescribe receptor structure and therefore suppleently bound to receptors in the membranes of ments binding assays, which measure site affinity target cells by using organic cross-linking reagents or number. Affinity labelling has been used in (Linsley et al., 1981 ). Such affinity labelling can studies of receptors for insulin (Yip et al., 1978 ; Abbreviations used: HBSS, Hanks balanced salt solu- Jacobs et al., 1979 Jacobs et al., , 1980 Pilch & Czech, 1979, tion; SDS, sodium dodecyl sulphate. 1980) , insulin-like growth factors I and II (Massa-* To whom correspondence and reprint requests tor (Linsley et al., 1979) , glucagon (Johnson et al., 1981) and angiotensin II (Paglin & Jamieson, 1982) .
125I-labelled human somatotropin, which interacts with somatogenic and lactogenic sites (Kelly et al., 1974; Ranke et al., 1976) , has been covalently coupled to receptors on hepatocytes from male rats (Donner, 1983) . Electrophoresis, on non-gradient SDS/polyacrylamide gels, of radioactivity solubilized from such cells in the absence of reductant, revealed complexes of Mr 300000, 220000 and 130000. A number of less-well-defined lower-Mr species were isolated from membranes solubilized in the presence of reductant. In these experiments the efficiency of cross-linking was low and it was therefore not possible to completely distinguish lactogenic from somatogenic complexes. In particular, the properties of the faint 220000-Mr species remained unresolved.
The goals of this study were to affinity-label somatotropin and prolactin receptors on hepatocytes isolated from female rats with 125I-bovine somatotropin and 125I-prolactin, in addition to 125I-human somatotropin. We also wished to increase the efficiency of hormone cross-linking to these receptors and then, by using SDS/polyacrylamide gradient gels, to resolve somatogenic from lactogenic complexes and particularly to determine if the 220000-Mr complex isolated previously (Donner, 1983) was a component of the somatotropin or the prolactin receptor.
Experimental procedures

Materials
The sources of all materials were described previously (Donner, 1983) .
General methods Purified human somatotropin was prepared by Dr. Brij Saxena (Cornell University Medical College) (Saxena & Henneman, 1966) . Human somatotropin monomer was isolated by gel filtration and was used in all studies. This hormone possessed an activity of 1.0i.u./mg as determined by weight-gain assay in the hypophysectomized rat (Donner et al., 1978b) . Monomeric human somatotropin, bovine somatotropin (from Dr. Martin Sonenberg, Sloan-Kettering Institute), and ovine prolactin (38.9i.u./mg; Sigma) were labelled with 1 251 by the method of Greenwood et al. (1963) and Lesniak et al. (1973) . The specific radioactivities of these species (65-125Ci/g) were determined by assaying the incorporation of 125I into a 20pg sample of-hormone by precipitation in trichloroacetic acid or by gel filtration. I25I-labelled hormone was separated from free 1 251 by elution of the reaction mixture from a column (0.9cm x 27 cm) of Sephadex G-75. Each labelled hormone was more than 95% precipitable in 5% (w/v) trichloroacetic acid. Hepatocytes were prepared by modification of the method of Berry & Friend (1969) as previously described (Donner et al., 1978a) . The binding of labelled hormones to hepatocytes was assayed by centrifugation (Donner et al., 1978b) .
Cross-linking protocols Hepatocytes (_ 106cells/ml) were incubated with 125I-labelled hormone (5 nM unless stated otherwise) in HBSS (Grand Island Biological Co.)/1% bovine serum albumin at 23°C for 60min. The incubation mixture was centrifuged (1500g for 3min) and the supernatant was aspirated from above the resultant cell pellet. The cell pellet was resuspended in ice-cold HBSS without albumin and re-centrifuged. This process was repeated two additional times to remove albumin and unbound hormone from the hepatocytes. The hepatocytes were resuspended in HBSS at 15°C and freshly prepared disuccinimidyl suberate in dimethyl sulphoxide was added to a final concentration of 1 mM. After 15 min the reaction was terminated by addition of 10 vol. of ice-cold lOmM-Tris/1 mM-EDTA/ 40mM-N-ethylmaleimide, pH 7.4. The mixture was centrifuged (1500g, 3min) and resuspended in icecold 0.25 M-sucrose/40mM-N-ethylmaleimide. The hepatocytes were disrupted in a Dounce homogenizer with a tight-fitting pestle (30 strokes) and drawn through a 22-gauge needle (10 times) until optical microscopy verified that virtually none of the cells remained intact. The homogenate was centrifuged at 800g for 10min, and the supernatant was centrifuged at 80000g for 15min to yield a crude membrane pellet to which 125I-labelled hormone was covalently bound. This pellet was boiled for 5min in solubilization medium containing 3% (w/v) SDS/10% (v/v) glycerol/6M-urea/ 0.001% Bromophenol Blue/0.06M-Tris/HCl/ 40mM-N-ethylmaleimide with or without 100mM-dithiothreitol.
Electrophoresis and autoradiography
The samples were analysed on gradient gels, containing 4-20% acrylamide (100: 1 acrylamide/bisacrylamide ratio), that were 1.5mm thick; the discontinuous buffer system described by Laemmli (1970) (Fig. 2a) . Bovine somatotropin or prolactin competed for 1 251 human somatotropin binding, prolactin being more effective in this regard. The binding of 1251-prolactin was inhibited by human somatotropin or prolactin, which were equally effective competitors (Fig. 2b) and 50000) were similar in female (Fig. 3 , lanes a and i) and male (Donner, 1983) rats. Incubations were also conducted with 1 251-human somatotropin and various concentrations of bovine somatotropin, prolactin or human somatotropin to distinguish somatogenic from lactogenic complexes. Bovine somatotropin inhibited the incorporation of 125I-human somatotropin into complexes of Mr 300000, 220000 and 130000 in a dosedependent manner, but had little or no effect on uptake into complexes of Mr 65000 or 50000 (Fig.  3 , lanes e-g). Low concentrations of prolactin eliminated 125I-human somatotropin uptake into complexes of Mr 65 000 and 50000 (Fig. 3, lanes (Fig. 4, lane d) . Prolactin . 1 25I-human somatotropin cross-linking to hepatocytes from female rats Hepatocytes (_ 106/ml) were incubated with 1251-human somatotropin (5nM) for 1 h at 23°C with: lane a, no unlabelled hormone (control); b, 9nM-prolactin; c, 900nM-prolactin; d, 6000nM-prolactin; e, 9nM-bovine somatotropin; f, 90nM-bovine somatotropin; g, 900nM-bovine somatotropin; h, 900nM-human somatotropin; i, no unlabelled hormone (control). Cross-linking of bound hormone was then carried out and a crude membrane fraction was prepared from each incubation mixture. Membranes were solubilized in the absence of reductant and equal volumes of extract (not equal amounts of radioactivity) from each incubate were subjected to electrophoresis on a linear 4-20%-polyacrylamide gradient gel. (Fig. 4) rather than equal volumes of solubilized membrane protein (Fig. 3 ) from various incubation mixtures. This was true, since solubilized membranes from incubation mixtures containing somatotropin (Fig. 3, lane h ) contained much less radioactivity than similar incuibation mixtures with 1 251-human somatotropin alone or in the presence of prolactin or bovine somatotropin. A lowMr (40000) complex resulted from non-specific cross-linking between hormone and another species, since native bovine somatotropin (Fig. 4 , lane a), prolactin (Fig. 4, lane g ) or human somatotropin (results not shown) did not prevent incorporation of labelled hormone into this species.
The specificity of the uptake of '25lprolactin into complexes of Mr 65000 and 50000 was tested in competition experiments (Fig. 5) of dithiothreitol, and equal amounts of radioactive label from each extract were subjected to electrophoresis on a linear 5-15% (w/v)-polyacrylamide gel (acrylamide/bisacrylamide ratio 37.5: 1).
Discussion
Previously (Donner, 1983) 125I-human somatotropin was covalently coupled to sites on hepatocytes from male rats. In that study it was not possible to unambiguously resolve somatogenic from lactogenic receptors and, in particular, to determine whether a 220000-Mr complex resulted from hormone binding to the somatotropin receptor or the prolactin receptor. Significantly, these difficulties have been overcome by use of hepatocytes from female rats. Prolactin and somatotropin receptors were labelled more efficiently on cells from female than male rats (Figs. 5 and 6 ). One explanation for this could be that the greater number of prolactin receptors on hepatocytes from female rats facilitated covalent labelling. We consider this unlikely, since somatotropin receptors, present in about equal numbers on hepatocytes from rats of either sex, were also labelled more efficiently on cells from female animals. Since somatogenic and lactogenic receptors on cells from female or male rats appear identical, the accessibility of these sites to the cross-linking reagent is probably different. The high efficiency of cross-linking to cells from female animals reduced the fraction of non-specifically coupled radioactivity and assisted the interpretation of experimental observations.
Competition for binding characterized the sites to which human somatotropin, bovine somatotropin and prolactin bind on hepatocytes from male or female rats (Kelly et al., 1974; Donner, 1983;  Figs. 1 and 2) . Bovine somatotropin or prolactin inhibited a component of the uptake of 1251-human somatotropin. Human somatotropin and prolactin, but not bovine somatotropin, competed for ' 25I-prolactin binding to hepatocytes from female or male rats. Prolactin, however, did not compete for l 25I-bovine somatotropin uptake, whereas bovine and human somatotropin were equally effective in this regard. These observations and the activities of these hormones ( K. Yamada and D. B. Donner Frantz, 1971; Li, 1972) suggest that bovine somatotropin and prolactin bind to somatogenic and lactogenic receptors respectively. Human somatotropin, which possesses weak lactogenic (Kleinberg & Frantz, 1971) as well as growthpromoting activity (Evans et al., 1943) , binds to somatogenic and prolactin receptors (Kelly et al., 1974; Ranke et al., 1976; Donner, 1983) .
The specificities of human somatotropin, bovine somatotropin and prolactin for binding to cells from female rats distinguished somatotropin from prolactin receptors. I251-human somatotropin was taken into complexes of 300000, 220000, 130000, 65000 and 50000Mr, Bovine somatotropin inhibited the incorporation of 1251-human somatotropin into complexes of Mr 300000, 220000 and 130000 without affecting the isolation of the 65 000-and 50000-Mr species. Low concentrations of prolactin competed for l 251-human somatotropin incorporation into complexes of Mr 65000 and 50000 (Fig. 3) . These experiments suggest that (1251.
human somatotropin)-receptor complexes can be segregated into somatogenic (Mr 300000, 220000 and 130000) and lactogenic (Mr 65000 and 50000) subgroups.
The assignment of the complexes into which 1251-human somatotropin was incorporated as somatogenic or lactogenic was verified by affinity labelling with I251-bovine somatotropin or 125I-prolactin. l25I-bovine somatotropin bound to receptors to yield species of Mr 300000, 220000 and 130000 (Fig. 4) ; Mr = 37000), rat (Borst & Sayare, 1982 ; Mr = 36000) or rabbit (Haeuple et al., 1983 ; Mr = 35000) liver and rabbit mammary membranes (Haeuple et al., 1983) .
Previously (Donner, 1983) it was considered possible that the 220000-Mr complex formed by binding somatotropin to hepatocytes might result from interaction with components of the receptor for prolactin. This proposal was considered viable, although unproven, since partially purified prolactin receptors have apparent-Mr values of about 220000 (Shiu & Friesen, 1974) . It has now been demonstrated that the 220000-Mr complex described here is a component of the somatotropin receptor. Subtracting the Mr of somatotropin from that of the somatogenic complexes suggests that the hormone had bound to species of Mr 280000, 200000 and 100000. The 300000-and 220000-Mr complexes were not isolated from reduced membranes (Fig. 6) , whereas the amount of the 130000-Mr species was augmented (Donner, 1983) . As with insulin receptors (Kasuga et al., 1982) or somatotropin receptors from male rats (Donner, 1983) , monomeric subunits were identified in the absence of reductant in solubilized membranes from cells from female animals (Figs. 3 and 4) . These observations imply that the somatotropin receptor is an aggregate in which some subunits are retained in a larger complex by interchain disulphide bonds.
Affinity labelling identified a 130000-Mr somatotropin-receptor complex on IM-9 lymphocytes (Hughes et al., 1983) . A somatotropin receptor of Mr 300000 from pregnant-rabbit liver mem-Somatotropin receptor 369 branes contained a component of Mr 75000 (Waters & Friesen, 1979) . A number of complexes of Mr less than 130000 were isolated after affinitylabelling receptors on microsomal fractions of rabbit liver (Haeuple et al., 1983; Hughes et al., 1983) , rabbit mammary gland and rat liver (Hughes et al., 1983) . In affinity-labelling experiments with hepatocytes from male rats, Donner (1983) identified a number of minor, low-Mr complexes into which somatotropin was bound. In evaluating structure, it is possible that not all of the components of the somatotropin receptor have been identified, and others may be labile. The isolation of major complexes of Mr 300000, 220000 and 130000 might suggest that a major component of the somatotropin receptor is a trimeric aggregate of 100000-Mr subunits. Further study is required to evaluate the minor, low-Mr complexes identified in other studies and to determine if additional subunits of this receptor are present.
